Spire Wealth Management’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-50
| Closed | -$1.26K | – | 2486 |
|
|
2024
Q4 | $1.26K | Hold |
50
| – | – | ﹤0.01% | 2331 |
|
|
2024
Q3 | $1.7K | Hold |
50
| – | – | ﹤0.01% | 2026 |
|
|
2024
Q2 | $1.85K | Hold |
50
| – | – | ﹤0.01% | 2020 |
|
|
2024
Q1 | $2.1K | Hold |
50
| – | – | ﹤0.01% | 2087 |
|
|
2023
Q4 | $2K | Hold |
50
| – | – | ﹤0.01% | 2141 |
|
|
2023
Q3 | $1.38K | Hold |
50
| – | – | ﹤0.01% | 2202 |
|
|
2023
Q2 | $1.7K | Hold |
50
| – | – | ﹤0.01% | 2226 |
|
|
2023
Q1 | $1.8K | Buy |
+50
| New | +$1.8K | ﹤0.01% | 2284 |
|